MarketPulse
M

$MGNX

2 articles found
0 positive
1 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

MacroGenics Schedules March Investor Roadshow Across Four Major Healthcare Conferences

MacroGenics to participate in four major healthcare investor conferences in March 2026, with management presenting on pipeline developments and business operations.
MGNXinvestor conferencefireside chat
GlobeNewswire Inc.GlobeNewswire Inc.··Macrogenics, Inc.

MacroGenics Halts New Patient Enrollment in LINNET Trial Following FDA Clinical Hold

FDA places partial clinical hold on MacroGenics' LINNET trial due to serious adverse events including thrombocytopenia, myocarditis, and one death. New enrollment halted.
MGNXFDA clinical holdbispecific antibody